1.Preparation of 3D printed metoprolol tartrate chewable tablets and optimization of printing process
Shan-shan WANG ; Xiao-lu HAN ; En LIANG ; Cong-hui LI ; Chun-yan LIU ; Ming-yuan LI ; Zeng-ming WANG ; Peng YU ; Ai-ping ZHENG
Acta Pharmaceutica Sinica 2023;58(9):2811-2817
		                        		
		                        			
		                        			 With the growing demand of personalized medicine for children, it is especially important to develop medicines for children. In this study, using metoprolol tartrate as model drug, we developed 3D printed chewable tablets suitable for children with automated dosage distribution using semi-solid extruded (SSE) 3D printing technology. Based on the quality by design concept, this study prepared a semi-solid material with good printability using gelatin as the substrate, constructed 3D models and printed tablets with the aid of computer-aided design. The printing parameters were optimized and determined as follows: print temperature of 35-37 ℃, print speed of 25 mm·s-1, fill rate of 15%, and number of outer profile layers of 2. Subsequently, the printing process and the quality uniformity of the tablets were verified, and a linear relationship between the dose and the number of model layers was obtained. Finally, 3D printed chewable tablets were superior in terms of appearance, dose accuracy and compliance compared with traditional split-dose commercially available tablets. In this study, 3D printed metoprolol tartrate chewable tablets with good performance were successfully prepared to address the personalized medication needs of pediatric patients. 
		                        		
		                        		
		                        		
		                        	
2.Changes of YAP activity at the early stage of nonalcoholic steatohepatitis and its spatiotemporal relationship with ductular reaction in mice.
Ya Xue LIU ; Jia En LIANG ; Wei Lan ZENG ; Yan WANG
Journal of Southern Medical University 2022;42(9):1324-1334
		                        		
		                        			OBJECTIVE:
		                        			To explore the changes in Yes-associated protein (YAP) activity at the early stage of nonalcoholic steatohepatitis (NASH) and the spatiotemporal relationship between YAP and ductular reaction (DR).
		                        		
		                        			METHODS:
		                        			Male C57BL/6J mouse models of NASH were established by feeding with a methionine- and choline-deficient (MCD) diet or a thioacetamide (TAA) diet for 12 weeks. At different time points during the feeding, liver histology of the mice was observed with HE and Masson trichrome staining. The mRNA expressions of YAP and its target genes (Ctgf, Cyr61, Acta2) were determined by qPCR, and the total protein expression level of YAP was measured with immunoblotting. The expression and distribution of YAP and the markers of DR (K19 and Sox9) were observed with immunohistochemical staining.
		                        		
		                        			RESULTS:
		                        			At the early stage of NASH induced by MCD diet (1 to 4 weeks), the mRNA expression of YAP and its target genes and the total protein expression of YAP increased significantly (P < 0.01). The number of YAP-positive hepatocytes reached the peak level of 90.8 (cells per ×400 field of view) at week 2 and then decreased to 30.8 at week 4 (P < 0.001); YAP-positive ductular cells appeared near the portal area, where DR began to occur. From 8 to 12 weeks, numerous K19/Sox9-positive DR cells were observed in the hepatic lobules around the central vein (P < 0.01), while only a few YAP-positive hepatocytes were present in the liver tissue (P > 0.05), and the number of YAP-positive ductular cells gradually increased with time (P < 0.001). At the early stage of NASH induced by TAA diet (3 days to 2 weeks), the mRNA expression of YAP and its target genes and the total protein expression of YAP increased significantly (P < 0.05), and the number of YAP-positive hepatocytes reached the peak of 69.2 at week 2 and then decreased to 55.2 at week 4 (P < 0.001); YAP-positive ductular cells first appeared at the initial location of DR near the central vein. From 6 to 12 weeks, numerous K19/Sox9-positive DR cells occurred in the hepatic lobules around the central vein (P < 0.01). While the number of YAP-positive hepatocytes decreased (P < 0.001), the number of YAP-positive ductular cells continued to increase (P < 0.001).
		                        		
		                        			CONCLUSION
		                        			During the development of NASH, YAP activation occurs earlier than DR but they are spatiotemporally correlated. YAP activation in hepatocytes may participate in DR by promoting hepatocyte dedifferentiation.
		                        		
		                        		
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Choline
		                        			;
		                        		
		                        			Disease Models, Animal
		                        			;
		                        		
		                        			Hepatocytes
		                        			;
		                        		
		                        			Liver/metabolism*
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Methionine/metabolism*
		                        			;
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Mice, Inbred C57BL
		                        			;
		                        		
		                        			Non-alcoholic Fatty Liver Disease/metabolism*
		                        			;
		                        		
		                        			RNA, Messenger/metabolism*
		                        			;
		                        		
		                        			Thioacetamide/metabolism*
		                        			;
		                        		
		                        			YAP-Signaling Proteins
		                        			
		                        		
		                        	
3.Visualization and application method of acupuncture-moxibustion knowledge of senile dementia in ancient books based on partial order structure.
En-Liang YAN ; Li-Ming LU ; Chun-Zhi TANG
Chinese Acupuncture & Moxibustion 2022;42(12):1421-1426
		                        		
		                        			
		                        			Acupuncture-moxibustion has affirmative curative effect in the prevention and treatment of senile dementia. Starting from the literature research, a visualization and application method of acupuncture-moxibustion knowledge of senile dementia in ancient books based on partial order structure is proposed. This method could extract and integrate the acupuncture-moxibustion knowledge of senile dementia contained in ancient books of traditional Chinese medicine, and establish a standardized, structured and visual knowledge graph. Applying this method to knowledge visual analysis and clinical auxiliary guidance could provide reference for combing the knowledge of ancient books of traditional Chinese medicine and transforming the knowledge of ancient books into clinical application.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Alzheimer Disease
		                        			;
		                        		
		                        			Medicine, Chinese Traditional
		                        			
		                        		
		                        	
4.Therapeutic effect of Jingfang Granules on CCl_4-induced liver fibrosis in mice and its mechanism.
Yu-Ru LI ; Ya-Fang ZHAO ; Guo-Liang CHENG ; En-Li WANG ; Yu-Jun TAN ; Jing-Chun YAO ; Yan ZHAO ; Gui-Min ZHANG
China Journal of Chinese Materia Medica 2022;47(22):6127-6136
		                        		
		                        			
		                        			To investigate the therapeutic effect of Jingfang Granules on carbon tetrachloride(CCl_4)-induced liver fibrosis in mice and its mechanism. Forty-nine 8-week-old male C57 BL/6 J mice were randomly divided into a blank group, a CCl_4 group, a silybin group(positive control, 100 mg·kg~(-1))+CCl_4, a Jingfang high-dose(16 g·kg~(-1)) group, a Jingfang high-dose(16 g·kg~(-1))+CCl_4 group, a Jingfang medium-dose(8 g·kg~(-1))+CCl_4 group, and a Jingfang low-dose(4 g·kg~(-1))+CCl_4 group, with 7 mice in each group. The mice in the blank group and Jingfang high-dose group were intraperitoneally injected olive oil solution, and mice in other groups were intraperitoneally injected with 10% CCl_4 olive oil solution(5 mL·kg~(-1)) to induce liver fibrosis, twice a week with an interval of 3 d, for 8 weeks. At the same time, except for the blank group and CCl_4 group, which were given deionized water, the mice in other groups were given the corresponding dose of drugs by gavage once daily for 8 weeks with the gavage volume of 10 mL·kg~(-1). All mice were fasted and freely drank for 12 h after the last administration, and then the eyeballs were removed for blood collection. The liver and spleen were collected, and the organ index was calculated. The levels of alanine aminotransferase(ALT), aspartate aminotransferase(AST), total bile acid(TBA), and triglyceride(TG) in the serum of mice were detected by an automated analyzer. Tumor necrosis factor-α(TNF-α), interleukin-6(IL-6) and interleukin-1β(IL-1β) levels were detected by enzyme-linked immunosorbent assay(ELISA). Kits were used to detect the contents of superoxide dismutase(SOD), malondialdehyde(MDA), and glutathione(GSH) in the liver tissue. Pathological changes in the liver tissue were observed by hematoxylin-eosin(HE), Masson, and Sirius red staining. Western blot was used to detect protein expressions of transforming growth factor-β(TGF-β), α-smooth muscle actin(α-SMA) and Smad4 in the liver tissue. The results indicated that Jingfang Granules significantly reduced the organ index, levels of ALT, AST, TBA,TG, TNF-α, IL-6, and IL-1β in the serum, and the content of MDA in the liver tissue of mice with CCl_4-induced liver fibrosis. Jingfang Granules also significantly increased the content of SOD and GSH in the liver tissue. Meanwhile, Jingfang Granules down-regulated the protein levels of TGF-β, α-SMA, and Smad4. Furthermore, Jingfang Granules had no significant effect on the liver tissue morphology and the above indexes in the normal mice. In conclusion, Jingfang Granules has obvious therapeutic effect on CCl_4-induced liver fibrosis, and its mechanism may be related to reducing the expression of pro-inflammatory factors, anti-oxidation, and regulating TGF-β/Smad4 signaling pathway.
		                        		
		                        		
		                        		
		                        			Mice
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Animals
		                        			;
		                        		
		                        			Tumor Necrosis Factor-alpha/metabolism*
		                        			;
		                        		
		                        			Interleukin-6/metabolism*
		                        			;
		                        		
		                        			Olive Oil/therapeutic use*
		                        			;
		                        		
		                        			Carbon Tetrachloride/metabolism*
		                        			;
		                        		
		                        			Liver Cirrhosis/metabolism*
		                        			;
		                        		
		                        			Liver
		                        			;
		                        		
		                        			Superoxide Dismutase/metabolism*
		                        			;
		                        		
		                        			Transforming Growth Factor beta/metabolism*
		                        			
		                        		
		                        	
5.Application of Shakubatrivalsartan in 5 cases of pediatric dilated cardiomyopathy: case report and literature review
Ying′en CHEN ; Jianhua LI ; Hao LIANG ; Yan LI ; Caiyan BAI ; Fei LIN ; Guoan ZHAO ; Zhigang CHEN
Chinese Journal of Applied Clinical Pediatrics 2021;36(24):1900-1902
		                        		
		                        			
		                        			Objective:To investigate the safety and therapeutic effect of Shakubatrivalsartan in the treatment of pediatric dilated cardiomyopathy.Methods:Clinical information, treatment and prognosis of 5 cases with dilated cardiomyopathy in the First Affiliated Hospital of Xinxiang Medical University from June 2018 to December 2020 were retrospectively analyzed, and relevant literatures were reviewed.Results:A total of 5 cases of children with dilated cardiomyopathy were analyzed, including 3 males and 2 females with age of 12-17 years.Their median left ventricular ejection fraction (LVEF), left ventricular end diastolic dimension (LVDd), N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels were 37% (20%-41%), 61 mm (59-67 mm), and 13 250 ng/L (12 310-21 823 ng/L), respectively.The median conventional treatment time was 5 months (1-12 months), in which, the condition of heart failure gradually progressed, and the median LVEF, LVDd and NT-proBNP levels were reduced to 33% (19%-37%), 61 mm (60-74 mm), 13 144 ng/L (8 086-15 137 ng/L). After less than 3 months of follow-up following conventional treatment plus Shakubatrivalsartan, NT-proBNP level significantly decreased in 5 cases.Besides, 4 cases had improved cardiac function, and the other one′s improvement was not obvious.The blood pressure of 5 cases decreased at varying degrees after medication of Shakubatrivalsartan, which should be closely monitored during drug titration.No adverse reactions were reported.Conclusions:Shakubatrivalsartan for the treatment of pediatric dilated cardiomyopathy is safe and effective, which can alleviate or reverse the process of myocardial remodeling and improve cardiac ejection fraction, thus improving the prognosis.
		                        		
		                        		
		                        		
		                        	
6.Extract from Modified Xiao Xianxiongtang Inhibits Epithelial-mesenchymal Transition and Invasion and Migration Mediated by TGF-β1 of Human Gastric Cancer MGC-803 Cells via Wnt5a/Ca2+/NFAT Signaling Pathway
Rui DING ; Rui-rui GE ; En-yu WANG ; Xing-hui HONG ; Liang WANG ; Peng ZHOU ; Jing SHAO ; Hai-yan FANG ; Hui SHI ; Jing-hui WANG ; Jin-ling HUANG
Chinese Journal of Experimental Traditional Medical Formulae 2021;27(4):37-46
		                        		
		                        			
		                        			Objective:This studu aims to investigate the effect of aqueous extract of modified Xiao Xianxiongtang on the epithelial mesenchymal transition(EMT) and the change of its invasion and migration ability of human gastric cancer MGC-803 cells mediated by transforming growth factor-
		                        		
		                        	
7.Emergency Response for a Laboratory Biosafety Incident.
En Min ZHANG ; Jia Qi WANG ; Li Dong GAO ; Zhi Fei ZHAN ; Heng ZHANG ; Yan Hong HU ; Jian Chun WEI ; Xu Dong LIANG ; Kang Lin WAN ; Qiang WEI
Biomedical and Environmental Sciences 2019;32(3):231-233
		                        		
		                        			
		                        			On December 14, 2017, a faculty member of a university in Hunan Province reported that an anthrax vaccine strain might have recovered virulence during an undergraduate experiment and potential exposure could not be ruled out for the students involved. Upon receiving the case report, the CDC, health bureaus, and local governments at the county, prefectural, and provincial levels promptly organized experts in different fields (including epidemiologists, biosafety experts, and laboratory testing experts) for case investigation, evaluation, and response. As the investigation results showed, no virulence recovery was identified in the involved anthrax vaccine strain; and no contamination of Bacillus anthracis was detected at the involved areas. Thus, the university returned to normal functioning.
		                        		
		                        		
		                        		
		                        			Anthrax Vaccines
		                        			;
		                        		
		                        			analysis
		                        			;
		                        		
		                        			Bacillus anthracis
		                        			;
		                        		
		                        			pathogenicity
		                        			;
		                        		
		                        			China
		                        			;
		                        		
		                        			Containment of Biohazards
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Laboratories
		                        			;
		                        		
		                        			statistics & numerical data
		                        			;
		                        		
		                        			Virulence
		                        			
		                        		
		                        	
9.Thrombopoietin Prevents CoCl-inducing Apoptosis of HUVEC through the PI3K/AKT Pathway.
Jun-Yan WANG ; Jie-Yu YE ; En-Yu LIANG ; Mo YANG
Journal of Experimental Hematology 2018;26(2):528-534
OBJECTIVETo investigate the effect of thrombopoietin (TPO) on chemical hypoxia-induced apoptosis of human umbilical vein endothelial cells (HUVEC), and to explore its potential mechanism.
METHODSThe experiment was divided into 4 groups. The untreated HUVECs were used as normal control group. HUVECs treated with CoCl was CoCl group, and TPO was added into the culture medium 48 h before CoCl treatment as TPO + CoCl group. The cells was treated with TPO alone as TPO group. The cell viability and apoptosis of each groups were tested by Cell Counter Kit 8 (CCK-8) assay and flow cytometry. The expression of Caspase-3 and mitochondrial membrane potential (MMP) were then determined by flow cytometry with Caspase-3-PE and JC-1. The effect of TPO in PI3K/AKT pathway was detected by using Western blot.
RESULTSCoCl significantly inhibited the growth of HUVECs. The cell viability of HUVECs decreased gradually with enhancement of CoCl at a gradient of chemical concentrations (r= -0.997). CoCl dramatically increased apoptosis of HUVECs, whereas pre-treatment with TPO rescued cell apoptosis induced by CoCl (P<0.001). Further investigation found that TPO decreased the expression of Caspase-3 and inhibited the reduction of MMP induced by CoCl (P<0.05). TPO could increased the activation of PI3K/AKT pathway in HUVECs.
CONCLUSIONTPO has a protective effect against CoCl-induced apoptosis of HUVECs through activating the PI3K/AKT pathway, thus decreasing the expression of apoptosis protease Caspase-3 and inhibiting the reduction of MMP.
Apoptosis ; drug effects ; Cells, Cultured ; Cobalt ; Human Umbilical Vein Endothelial Cells ; Humans ; Phosphatidylinositol 3-Kinases ; Proto-Oncogene Proteins c-akt ; Signal Transduction ; Thrombopoietin
10.Effects of Gualou Xiebai Banxia decoction on blood lipid content, oxidative stress and ox-LDL/Lox-1 pathway in ApoE-/- mice.
Jian-En GUO ; Shu-Bin MI ; Xiu-Chuan YAN ; Si-Yuan XIN ; Fei GAO ; Guang-He LIANG ; Jing-Hua LI
China Journal of Chinese Materia Medica 2017;42(4):752-757
		                        		
		                        			
		                        			To observe the functions of Gualou Xiebai Banxia decoction(GXBD) on regulating lipid metabolism, anti-oxidation, and interposing ox-LDL/Lox-1 pathway, and to explore its anti-atherosclerosis (AS) mechanisms. AS models were established by using 42 Apo-E-/- male mice with high fat diet. AS model mice were randomly divided into the model group, simvastatin group, and GXBD high and low dose groups. C57BL/6J male mice were used as the normal control group, n=10 and the treatment lasted for 8 weeks. The levels of TC, TG, LDL-C, HDL-C, SOD, MDA, GSH-px, and ox-LDL in blood serum were tested 24 h after the last administration. The changes of aortic tissues structure were observed by HE staining; the expression levels of Lox-1 protein and the expression levels of mRNA were detected by Western blot and PCR respectively.Results showed that the blood lipid levels and MDA, ox-LDL levels in blood serum of model group were significantly higher than those in the normal control group, but SOD, GSH-px levels were significantly lower than those in the normal control group, and the Lox-1 protein and mRNA expression levels were also significantly higher than those in the control group(P<0.05), namely aortic atherosclerosis lesions were obvious in model group.The levels of blood lipid and MDA, ox-LDL of GXBD high and low dose groups and simvastatin group were significantly lower than those in model group, while SOD, GSH-px levels were significantly higher than those in model group, and Lox-1 protein and mRNA expression levels were significantly lower than those in model group(P<0.05), namely the aortic atherosclerosis lesions were significantly relieved. The above results indicated that GXBD was capable of modulating blood lipid, anti-oxidation, and inhibiting the expression of Lox-1, and interposing ox-LDL/Lox-1 pathway in the AS model Apo-E-/- mice, which may be one of the mechanisms of anti-atherosclerosis.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail